We are pleased to announce the Litmus Health Advisory Board, a broad and diverse group of leaders whose expertise spans business, technology, academia and pharmaceutical research.
Our own Dr. Sam Volchenboum has been published in WIRED. His post discusses the potential of social data to provide insights into a person’s health and well-being, and the ethical, technical, regulatory, and societal…
Thank you again to everyone who joined last week’s live discussion about Clinical Trials of the Future with Drs. Sam Volchenboum and Sam Blackman. We were flattered that so many of you were in attendance. We’ve already been asked to make this into a…
We invite you to join us on June 6th for a live conversation on Clinical Trials of the Future. The content is valuable for anyone interested in learning how new technologies are transforming how we conduct clinical…
We are delighted to announce Litmus Free. Our platform is now available to researchers in academia at zero cost.
Researchers can apply for Litmus Free here.
At a time when NIH’s budget is in…
Our co-founder and Chief Medical Officer Dr. Sam Volchenboum recently co-presented at Google Cloud Next with University of Chicago’s Dr. Michael Howell on sensitive data management for collaborative research clouds. The are two critical components of improving the pace…
Litmus Health has been accepted as a finalist for the SXSW Accelerator, hosted as part of the larger SXSW event in Austin, Texas.
Each year, the event draws tens of thousands of people from all over the world…
Today, the way in which clinical trials are run makes it hard to determine a drug’s impact on a patient’s quality of life. The primary endpoint for most drugs remains survival, meaning that the medication might help you…
Last week, Dr. Samuel Volchenboum spoke at AMIA in Chicago on the topic of health-related quality of life as the ultimate endpoint. From the viewpoint of a 32 year-old woman with Crohn’s Disease, it’s easy to see that quality of life should not be a second-hand consideration for drug…
Our co-founder and Chief Science Officer Dr. Sam Volchenboum recently spoke at the UChicago Innovation Fest at MATTER about how Litmus is working to increase the efficiency of clinical trials.
